Literature DB >> 12689901

Quantification of posterior capsule opacification with round and sharp edge intraocular lenses.

Gerd U Auffarth1, Ariadne Golescu, Klio A Becker, Hans E Völcker.   

Abstract

PURPOSE: To quantitatively evaluate and compare intraocular lenses (IOLs) with a round or sharp optic edge design for posterior capsule opacification (PCO). STUDY
DESIGN: Prospective comparative observational case series. PARTICIPANTS/MATERIALS: Photographs from 174 eyes were analyzed for PCO at the Department of Ophthalmology, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany. MAIN OUTCOME MEASURES: Part I: 121 eyes of 121 patients were analyzed for quantification of PCO. IOLs evaluated were Corneal ACR6 (n = 21), Alcon Acrysof (n = 20), Allergan AR40 (n = 27), Pharmacia 811 one-piece polymethyl methacrylate (PMMA) IOL (n = 24), and Pharmacia 911A silicone IOL (n = 29). Mean follow-up was 14.01 +/- 2.81 months; mean patient age was 73.2 +/- 7.3 years. The morphologic PCO formation was evaluated for the entire optic and in the central 3-mm zone. Part II: In 53 eyes of 46 patients aged 73.4 +/- 10.8 years with an Alcon Acrysof IOL, PCO formation and capsulorrhexis/optic overlapping were analyzed 34.2 +/- 4 months after cataract surgery using EPCO Software.
RESULTS: Part I: The PCO values of the entire optic were for Corneal ACR6, 1.93 +/- 0.62; PMMA, 0.64 +/- 0.63; AR40, 0.55 +/- 0.28; Alcon Acrysof, 0.145 +/- 0.27; and 0.161 +/- 0.181 for the Pharmacia 911A IOL (P < 0.01). The PCO values of the central 3-mm zone were for Corneal ACR6, 1.64 +/- 0.96; PMMA, 0.49 +/- 0.39; AR40, 0.22 +/- 0.32; Alcon Acrysof, 0.08 +/- 0.21; and 0.06 +/- 0.11 for the Pharmacia 911A IOL (P < 0.01). Part II: Average overlapping of capsulorrhexis and Acrysof IOL optic was 40.5% +/- 12.4%. There was a significant correlation between PCO values and overlapping (r = -0.69, P < 0.001).
CONCLUSIONS: The sharp-edge IOL types (Alcon Acrysof and Pharmacia 911A silicone IOL) resulted in statistically significantly lower PCO values for analysis of the entire optic area and central 3-mm zone. There was no statistically significant difference in PCO values between the two sharp-edge optic IOLs. An overlapping of capsulorrhexis rim and the anterior IOL optic surface of more than 20% resulted in significantly lower PCO values with the Acrysof IOL.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12689901     DOI: 10.1016/S0161-6420(02)01980-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  25 in total

1.  Single versus three piece acrylic IOLs.

Authors:  D F Chang
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

2.  [Influence of intraocular lens material and design on the development of posterior capsule opacification].

Authors:  O Nishi
Journal:  Ophthalmologe       Date:  2005-06       Impact factor: 1.059

Review 3.  [New methods for the prevention of posterior capsule opacification].

Authors:  G U Auffarth; T M Rabsilber; A J Reuland
Journal:  Ophthalmologe       Date:  2005-06       Impact factor: 1.059

4.  Prospective, non-randomised, long term clinical evaluation of a foldable hydrophilic single piece intraocular lens: results of the Centerflex FDA study.

Authors:  K A Becker; M Martin; T M Rabsilber; B B Entz; A J Reuland; G U Auffarth
Journal:  Br J Ophthalmol       Date:  2006-05-10       Impact factor: 4.638

5.  Long-term results of sealed capsule irrigation using distilled water to prevent posterior capsule opacification: a prospective clinical randomised trial.

Authors:  Tanja M Rabsilber; Il-Joo Limberger; Andreas J Reuland; Mike P Holzer; Gerd U Auffarth
Journal:  Br J Ophthalmol       Date:  2007-01-03       Impact factor: 4.638

6.  Effect of four different intraocular lenses on posterior capsule opacification.

Authors:  Rahmi Duman; Fatih Karel; Pelin Özyol; Can Ateş
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

7.  Accommodation after Nd: YAG capsulotomy in patients with accommodative posterior chamber lens 1CU.

Authors:  Nhung X Nguyen; B Seitz; S Reese; A Langenbucher; M Küchle
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-14       Impact factor: 3.117

8.  Cataract surgeon viewpoints on the need for novel preventative anti-inflammatory and anti-posterior capsular opacification therapies.

Authors:  Mahbubul H Shihan; Samuel G Novo; Melinda K Duncan
Journal:  Curr Med Res Opin       Date:  2019-08-28       Impact factor: 2.580

9.  EGF receptor inhibitor erlotinib as a potential pharmacological prophylaxis for posterior capsule opacification.

Authors:  C Wertheimer; R Liegl; M Kernt; W Mayer; D Docheva; A Kampik; K H Eibl-Lindner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-01-18       Impact factor: 3.117

10.  A prospective, randomised comparison of single and three piece acrylic foldable intraocular lenses.

Authors:  R Nejima; K Miyata; M Honbou; T Tokunaga; T Tanabe; M Sato; T Oshika
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.